Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280,909 | 301,450 | 226,563 | 155,585 | 194,719 |
| Marketable Securities | 973,129 | 846,971 | 749,025 | 682,057 | 512,281 |
| Receivables | 371,245 | 304,298 | 277,305 | 257,491 | 235,217 |
| Inventories | 135,991 | 116,234 | 105,963 | 101,252 | 98,102 |
| Income taxes - deferred | 53,047 | 107,583 | 135,974 | 162,847 | 197,567 |
| Other current assets | 13,692 | 0 | 0 | 0 | 0 |
| TOTAL | $1,849,694 | $1,707,367 | $1,531,776 | $1,395,014 | $1,265,898 |
| Non-Current Assets | |||||
| PPE Net | 223,106 | 211,809 | 206,789 | 198,951 | 198,200 |
| Other Non-Current Assets | 83,163 | 66,500 | 69,902 | 81,557 | 90,624 |
| TOTAL | $306,269 | $278,309 | $276,691 | $280,508 | $288,824 |
| Total Assets | $2,155,963 | $1,985,676 | $1,808,467 | $1,675,522 | $1,554,722 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 181 | N/A | N/A | N/A | 139 |
| Accounts payable and accrued liabilities | 47,552 | 33,551 | 29,986 | 28,105 | 35,649 |
| Accrued Expenses | 53,016 | 49,099 | 43,715 | 46,166 | 47,631 |
| TOTAL | $253,453 | $217,526 | $174,829 | $175,789 | $185,895 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234 | 293 | 304 | 331 | 323 |
| Deferred Revenues | 19,880 | 16,350 | 12,590 | 12,357 | 5,474 |
| Other Non-Current Liabilities | 0 | 345,000 | 345,000 | 345,000 | 345,000 |
| TOTAL | $31,638 | $372,878 | $366,475 | $367,636 | $365,853 |
| Total Liabilities | $285,091 | $590,404 | $541,304 | $543,425 | $551,748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,799,527 | 1,731,665 | 1,722,268 | 1,714,578 | 1,710,246 |
| Common Shares | 449 | 432 | 215 | 214 | 426 |
| Retained earnings | -4,272 | -114,516 | -227,756 | -339,215 | -453,643 |
| Other shareholders' equity | -19,231 | -158 | 1,743 | 6,979 | 3,201 |
| TOTAL | $1,870,872 | $1,395,272 | $1,267,163 | $1,132,097 | $1,002,974 |
| Total Liabilities And Equity | $2,155,963 | $1,985,676 | $1,808,467 | $1,675,522 | $1,554,722 |